These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


221 related items for PubMed ID: 8185754

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [On misery coast. Episode 1: the market of vital drugs].
    Chneiweiss H.
    Med Sci (Paris); 2003; 19(8-9):892-4. PubMed ID: 14593623
    [No Abstract] [Full Text] [Related]

  • 25. Impact of decentralization on health services in Uganda: a look at facility utilization, prescribing and availability of essential drugs.
    Anokbonggo WW, Ogwal-Okeng JW, Obua C, Aupont O, Ross-Degnan D.
    East Afr Med J; 2004 Feb; Suppl():S2-7. PubMed ID: 15125109
    [Abstract] [Full Text] [Related]

  • 26. Essential medicines for the whole world.
    Reidenberg MM.
    Clin Pharmacol Ther; 2007 Nov; 82(5):500-3. PubMed ID: 17952105
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Quality medicines for the poor: experience of the Delhi programme on rational use of drugs.
    Chaudhury RR, Parameswar R, Gupta U, Sharma S, Tekur U, Bapna JS.
    Health Policy Plan; 2005 Mar; 20(2):124-36. PubMed ID: 15746221
    [Abstract] [Full Text] [Related]

  • 29. Improving availability and affordability of plasma-derived medicines.
    Cheraghali AM, Abolghasemi H.
    Biologicals; 2010 Jan; 38(1):81-6. PubMed ID: 20137973
    [Abstract] [Full Text] [Related]

  • 30. Patents and access to drugs in developing countries: an ethical analysis.
    Sterckx S.
    Dev World Bioeth; 2004 May; 4(1):58-75. PubMed ID: 15086374
    [Abstract] [Full Text] [Related]

  • 31. Patently necessary: improving global access to essential medicines.
    CMAJ; 2003 Dec 09; 169(12):1257, 1259. PubMed ID: 14662658
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Learning from practice: compulsory licensing cases and access to medicines.
    Stirner B.
    Pharm Pat Anal; 2012 Nov 09; 1(5):555-75. PubMed ID: 24236925
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The World Health Organization's prequalification program and its potential effect on data exclusivity laws.
    Childs DW.
    Food Drug Law J; 2005 Nov 09; 60(1):79-97. PubMed ID: 15940855
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. International regulation of the supply and use of pharmaceuticals.
    Medawar C.
    Dev Dialogue; 1985 Nov 09; (2):15-37. PubMed ID: 12341045
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.